XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$6.53
-0.10 (-1.51%)
Open$6.57
Previous Close$6.63
Day High$6.64
Day Low$6.32
52W High$10.08
52W Low$4.30
Volume—
Avg Volume1.71M
Market Cap1.13B
P/E Ratio2,042.27
EPS$-0.02
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+614.4% upside
Current
$6.53
$6.53
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 301.50M | 217.93M | 186.74M |
| Net Income | 571.1K | 371.5K | 58.69M |
| Profit Margin | 0.2% | 0.2% | 31.4% |
| EBITDA | 36.92M | 25.35M | 67.69M |
| Free Cash Flow | — | — | 40.84M |
| Rev Growth | +38.4% | +38.4% | +1.9% |
| Debt/Equity | 16.10 | 16.10 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |